Inspire Medical Systems (INSP) Current Leases (2021 - 2022)

Inspire Medical Systems (INSP) reported Current Leases of $1.3 million for Q4 2022, up 328.21% on a YoY basis from $312000.0 in Q4 2021, and up 328.21% sequentially from $312000.0 in Q4 2021.

Inspire Medical Systems (INSP) Current Leases (2021 - 2022) Analysis & Trends

Inspire Medical Systems (INSP) has 2 years of Current Leases data on file, last reported at $1.3 million in Q4 2022.

  • For the quarter ending Q4 2022, Current Leases rose 328.21% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2022 stood at $1.3 million (up 328.21% YoY), and the FY2022 full-year result was $1.3 million, up 328.21% from the prior year.
  • Current Leases improved to $1.3 million in Q4 2022, from $312000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.3 million in Q4 2022 to a low of $312000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 24.30 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 20.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Inspire Medical Systems 1.46 Bn 1.17 Bn 176.91 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 1.34 Mn
Dec 31, 2021 312,000.00